Scout | Notice of Special Interest (NOSI): Advancing Research in Lipoprotein(a) and Cardiovascular Disease (R01 Clinical Trials Allowed) and (R01 No Clinical Trials Allowed)

This opportunity is no longer accepting applications.

grant

Notice of Special Interest (NOSI): Advancing Research in Lipoprotein(a) and Cardiovascular Disease (R01 Clinical Trials Allowed) and (R01 No Clinical Trials Allowed)

This grant opportunity encourages research on the role lipoprotein(a) plays in cardiovascular disease. It supports collaborative projects across various disciplines focusing on basic, preclinical, and clinical studies. The research should explore the biology and impacts of Lp(a) and work on creating new models and treatments.

Source

Agency: National Institutes of Health

Sub-agency: National Heart, Lung, and Blood Institute

Dates

Opportunity Released: November 10, 2022

Keywords

Lipoprotein(a)

Cardiovascular Disease

R01 Grant

Multidisciplinary Research

Basic Studies

Preclinical Studies

Mechanistic Clinical Studies

Pathophysiology

Clinical Implications

New Therapies.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers